602 related articles for article (PubMed ID: 31343125)
21. Plumbagin protects liver against fulminant hepatic failure and chronic liver fibrosis via inhibiting inflammation and collagen production.
Wang H; Zhang H; Zhang Y; Wang D; Cheng X; Yang F; Zhang Q; Xue Z; Li Y; Zhang L; Yang L; Miao G; Li D; Guan Z; Da Y; Yao Z; Gao F; Qiao L; Kong L; Zhang R
Oncotarget; 2016 Dec; 7(50):82864-82875. PubMed ID: 27756878
[TBL] [Abstract][Full Text] [Related]
22. Naringenin prevents experimental liver fibrosis by blocking TGFβ-Smad3 and JNK-Smad3 pathways.
Hernández-Aquino E; Zarco N; Casas-Grajales S; Ramos-Tovar E; Flores-Beltrán RE; Arauz J; Shibayama M; Favari L; Tsutsumi V; Segovia J; Muriel P
World J Gastroenterol; 2017 Jun; 23(24):4354-4368. PubMed ID: 28706418
[TBL] [Abstract][Full Text] [Related]
23. Endogenous production of n-3 polyunsaturated fatty acids protects mice from carbon tetrachloride-induced liver fibrosis by regulating mTOR and Bcl-2/Bax signalling pathways.
Shan C; Wang R; Wang S; Zhang Z; Xing C; Feng W; Zhao Z; Zhou S; Zhao AZ; Mu Y; Li F
Exp Physiol; 2021 Apr; 106(4):983-993. PubMed ID: 33605486
[TBL] [Abstract][Full Text] [Related]
24. Igf2bp2 knockdown improves CCl
Xu Z; He B; Jiang Y; Zhang M; Tian Y; Zhou N; Zhou Y; Chen M; Tang M; Gao J; Peng F
Int Immunopharmacol; 2022 Sep; 110():108987. PubMed ID: 35820364
[TBL] [Abstract][Full Text] [Related]
25. A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor-β and vascular endothelial growth factor signalling.
Liu Y; Wang Z; Wang J; Lam W; Kwong S; Li F; Friedman SL; Zhou S; Ren Q; Xu Z; Wang X; Ji L; Tang S; Zhang H; Lui EL; Ye T
Liver Int; 2013 Apr; 33(4):504-15. PubMed ID: 23279742
[TBL] [Abstract][Full Text] [Related]
26. Decursin attenuates hepatic fibrogenesis through interrupting TGF-beta-mediated NAD(P)H oxidase activation and Smad signaling in vivo and in vitro.
Choi YJ; Kim DH; Kim SJ; Kim J; Jeong SI; Chung CH; Yu KY; Kim SY
Life Sci; 2014 Jul; 108(2):94-103. PubMed ID: 24880074
[TBL] [Abstract][Full Text] [Related]
27. Induction of liver fibrosis by CCl4 mediates pathological alterations in the spleen and lymph nodes: The potential therapeutic role of propolis.
Sayed EA; Badr G; Hassan KA; Waly H; Ozdemir B; Mahmoud MH; Alamery S
Saudi J Biol Sci; 2021 Feb; 28(2):1272-1282. PubMed ID: 33613057
[TBL] [Abstract][Full Text] [Related]
28. Ethyl Acetate Fraction of Dicliptera chinensis (L.) Juss. Ameliorates Liver Fibrosis by Inducing Autophagy via PI3K/AKT/mTOR/p70S6K Signaling Pathway.
Liu Y; Bi YM; Pan T; Zeng T; Mo C; Sun B; Gao L; Lyu ZP
Chin J Integr Med; 2022 Jan; 28(1):60-68. PubMed ID: 34105096
[TBL] [Abstract][Full Text] [Related]
29. Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats.
Eissa LA; Kenawy HI; El-Karef A; Elsherbiny NM; El-Mihi KA
Chem Biol Interact; 2018 Oct; 294():91-100. PubMed ID: 30138605
[TBL] [Abstract][Full Text] [Related]
30. Ginkgo biloba extract mitigates liver fibrosis and apoptosis by regulating p38 MAPK, NF-κB/IκBα, and Bcl-2/Bax signaling.
Wang Y; Wang R; Wang Y; Peng R; Wu Y; Yuan Y
Drug Des Devel Ther; 2015; 9():6303-17. PubMed ID: 26664050
[TBL] [Abstract][Full Text] [Related]
31. Role of growth factor receptor-bound 2 in CCl
Ge S; Xiong Y; Wu X; Xie J; Liu F; He J; Xiang T; Cheng N; Lai L; Zhong Y
Biomed Pharmacother; 2017 Aug; 92():942-951. PubMed ID: 28618656
[TBL] [Abstract][Full Text] [Related]
32. Yu Gan Long Ameliorates Hepatic Fibrosis by Inhibiting PI3K/AKT, Ras/ERK and JAK1/STAT3 Signaling Pathways in CCl
Li HG; You PT; Xia Y; Cai Y; Tu YJ; Wang MH; Song WC; Quan TM; Ren HY; Liu YW; Dan HX; Xu SQ
Curr Med Sci; 2020 Jun; 40(3):539-547. PubMed ID: 32681257
[TBL] [Abstract][Full Text] [Related]
33. lncRNA GAS5 restrains CCl
Dong Z; Li S; Wang X; Si L; Ma R; Bao L; Bo A
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G539-G550. PubMed ID: 30735452
[TBL] [Abstract][Full Text] [Related]
34. Ligustrazin increases lung cell autophagy and ameliorates paraquat-induced pulmonary fibrosis by inhibiting PI3K/Akt/mTOR and hedgehog signalling via increasing miR-193a expression.
Liu MW; Su MX; Tang DY; Hao L; Xun XH; Huang YQ
BMC Pulm Med; 2019 Feb; 19(1):35. PubMed ID: 30744607
[TBL] [Abstract][Full Text] [Related]
35. Modulation of TGF-β/Smad and ERK signaling pathways mediates the anti-fibrotic effect of mirtazapine in mice.
El-Tanbouly DM; Wadie W; Sayed RH
Toxicol Appl Pharmacol; 2017 Aug; 329():224-230. PubMed ID: 28623179
[TBL] [Abstract][Full Text] [Related]
36. The common dietary flavonoid myricetin attenuates liver fibrosis in carbon tetrachloride treated mice.
Geng Y; Sun Q; Li W; Lu ZM; Xu HY; Shi JS; Xu ZH
Mol Nutr Food Res; 2017 Apr; 61(4):. PubMed ID: 27983763
[TBL] [Abstract][Full Text] [Related]
37. Camel Milk Ameliorates 5-Fluorouracil-Induced Renal Injury in Rats: Targeting MAPKs, NF-κB and PI3K/Akt/eNOS Pathways.
Arab HH; Salama SA; Maghrabi IA
Cell Physiol Biochem; 2018; 46(4):1628-1642. PubMed ID: 29694984
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-101 suppresses liver fibrosis by downregulating PI3K/Akt/mTOR signaling pathway.
Lei Y; Wang QL; Shen L; Tao YY; Liu CH
Clin Res Hepatol Gastroenterol; 2019 Oct; 43(5):575-584. PubMed ID: 30857885
[TBL] [Abstract][Full Text] [Related]
39. Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-β1/Smad and NOX4/ROS pathways.
Cheng Q; Li C; Yang CF; Zhong YJ; Wu D; Shi L; Chen L; Li YW; Li L
Chem Biol Interact; 2019 Feb; 299():131-139. PubMed ID: 30543783
[TBL] [Abstract][Full Text] [Related]
40. Human platelets inhibit liver fibrosis in severe combined immunodeficiency mice.
Takahashi K; Murata S; Fukunaga K; Ohkohchi N
World J Gastroenterol; 2013 Aug; 19(32):5250-60. PubMed ID: 23983427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
